NFKB1 and hepatocellular carcinoma: Wu et al. confirmed that TREM-1+ TAMs promote the recruitment of CCR6+Foxp3+ Tregs via the ERK/NF-κB pathway, conferring resistance to programmed cell death ligand 1 (PD-L1) treatment in HCC 78.